
PHA-848125 NEW
Price | $6 | $4 | $2 |
Package | 1KG | 5KG | 25KG |
Min. Order: | 1KG |
Supply Ability: | g-kg-ton |
Update Time: | 2025-07-28 |
Product Details
Product Name: PHA-848125 | CAS No.: 802539-81-7 |
Min. Order: 1KG | Purity: 99% |
Supply Ability: g-kg-ton | Release date: 2025/07/28 |
Lead time: in stock | Packaging: bag/bottle/drum//IBC, as request |
Delivery: By sea, by air, by express | Origin: Manufacturer, advantage products |
COA, MSDS: Available, contact us for details | Contact: Tina |
PHA-848125
![]() PHA-848125 structure | Common Name | PHA-848125 | ||
---|---|---|---|---|
CAS Number | 802539-81-7 | Molecular Weight | 460.575 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C25H32N8O | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A | |
Purity | Quantity | Budget | Inquiry |
---|
Use of PHA-848125Milciclib (PHA-848125) is a potent, dual inhibitor of CDK and Tropomyosin receptor kinase (TRK), with IC50s of 45, 150, 160, 363, 398 nM and 53 nM for cyclin A/CDK2, cyclin H/CDK7, cyclin D1/CDK4, cyclin E/CDK2, cyclin B/CDK1 and TRKA, respectively. |
Name | N,1,4,4-tetramethyl-8-[4-(4-methylpiperazin-1-yl)anilino]-5H-pyrazolo[4,3-h]quinazoline-3-carboxamide |
---|---|
Synonym | More Synonyms |
Description | Milciclib (PHA-848125) is a potent, dual inhibitor of CDK and Tropomyosin receptor kinase (TRK), with IC50s of 45, 150, 160, 363, 398 nM and 53 nM for cyclin A/CDK2, cyclin H/CDK7, cyclin D1/CDK4, cyclin E/CDK2, cyclin B/CDK1 and TRKA, respectively. |
---|---|
Related Catalog | Signaling Pathways >> Autophagy >> Autophagy Research Areas >> Cancer |
Target | cyclin A/CDK2:45 nM (IC50) cyclin E/CDK2:363 nM (IC50) cyclin H/CDK7:150 nM (IC50) cyclin D1/CDK4:160 nM (IC50) cyclin B/CDK1:398 nM (IC50) TRKA:53 nM (IC50) |
In Vitro | Milciclib (PHA-848125; 0.156 or 0.625 μM) up-regulates the expression of PDCD4, DDIT4, SESN2/sestrin 2 and DEPDC6/DEPTOR in GL-Mel cells[1]. Milciclib (PHA-848125) potently inhibits the kinase activity of CDK2/cyclin A complex and of TRKA in a biochemical assay, with IC50s of 45 and 53 nM, respectively. Milciclib induces a clear accumulation of cells in G1 phase. Milciclib strongly inhibits NGF-induced phosphorylation of TRKA in a dose-dependent manner[2]. |
In Vivo | Milciclib (PHA-848125; 5, 10, and 15 mg/kg, p.o.) inhibits the growth of tumor in 7,12-dimethylbenz(a) anthracene (DMBA)-induced rat mammary carcinoma model. Milciclib has significant antitumor activity in various human xenografts and carcinogen-induced tumors as well as in disseminated primary leukemia models, with plasma concentrations in rodents in the same range as those found active in inhibiting cancer cell proliferation[2]. Milciclib (PHA-848125; 40 mg/kg) induces a significant tumor growth inhibition in K-RasG12DLA2 mice, and this is accompanied by a reduction in the cell membrane turnover[3]. |
Cell Assay | Cells are seeded into 96- or 384-well plates at densities ranging from 10,000 to 30,000/cm2 in appropriate medium plus 10% FCS. After 24 hours, cells are treated in duplicate with serial dilutions of Milciclib, and 72 hours later, viable cell number is assessed using the CellTiter-Glo Assay. IC50s are calculated using a Sigmoidal fitting algorithm. Experiments are done independently at least twice. |
Animal Admin | Rats are randomized and introduced into the study when at least one mammary tumor attained a diameter of 0.5 cm. Groups of 10 animals are treated orally twice a day continuously for 10 days with vehicle (glucosate) or with 5, 10, and 15 mg/kg of Milciclib, whereas a further group receives two cycles of Milciclib at 20 mg/kg orally twice a day for 5 days with an intervening rest period of 1 week. Tumor volume is measured regularly by caliper for the duration of the experiment. |
References | [1]. Caporali S, Alvino E, Levati L, Esposito AI, Ciomei M, Brasca MG, Del Bufalo D, Desideri M, Bonmassar E, Pfeffer U, D'Atri S.Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125.Biochem Pharmacol. 2012 Sep 1;84(5):598-611. [2]. Albanese C, Alzani R, Amboldi N, Avanzi N, Ballinari D, Brasca MG, Festuccia C, Fiorentini F, Locatelli G, Pastori W, Patton V, Roletto F, Colotta F, Galvani A, Isacchi A, Moll J, Pesenti E, Mercurio C, Ciomei M.Dual targeting of CDK and tropomyosin receptor kinase families by the oral inhibitor PHA-848125, an agent with broad-spectrum antitumor efficacy.Mol Cancer Ther. 2010 Aug;9(8):2243-54. [3]. Degrassi A, et al. Efficacy of PHA-848125, a cyclin-dependent kinase inhibitor, on the K-Ras(G12D)LA2 lung adenocarcinoma transgenic mouse model: evaluation by multimodality imaging.Mol Cancer Ther. 2010 Mar;9(3):673-81. |
Density | 1.3±0.1 g/cm3 |
---|---|
Molecular Formula | C25H32N8O |
Molecular Weight | 460.575 |
Exact Mass | 460.269897 |
PSA | 94.70000 |
LogP | 1.75 |
Index of Refraction | 1.692 |
Storage condition | -20℃ |
Company Profile
Our company is a high-tech enterprise specializing in chemical raw materials such as electronic materials, optoelectronic materials, semiconductor materials, UV monomers, silane catalysts, cosmetic raw materials, etc. The company integrates research and development, production, customized synthesis, and sales, and is committed to providing customers with high-quality chemical product solutions.
Our Company
Our Advantage
Rich experience
Our products have been exported to many countries, including Germany, Spain, the United Kingdom, the United States, Australia, the Middle East, Asia, and more. We have received highly positive feedback from our clients and have established long-term friendly cooperative relationships with them.
Excellent quality, purity, and competitive price
Excellent quality is one of the cornerstones of our success. We welcome ordering samples for quality testing.
Safe and fast delivery
We will arrange shipment of spot products as soon as we receive payment.
Customized products are determined based on the synthesis time of different products.
Excellent pre-sales and after-sales service
Pre sales:
We are committed to providing the most favorable quotes and detailed information about our products and company.
after-sale service:
We assist buyers in customs clearance by providing necessary documents and information.
If there is any dispute over product quality, we are committed to providing the best solution.
? Packaging:
1kg/bag, 25kg/drum, 50kg/drum, 180kg/drum, 200kg/drum, 1T/bag/drum, standard export packaging or packaging required by customers
? Shipping
? Delivery:
Within 7 days after receiving your payment
Contact information
For more details, pls contact us freely.
Contact name: Tina
Email address: Tina@fdachem.com
Mob: 86 13213167925
WhatsApp/Skype/Wechat/LINE: 86 15225627621
Company Profile Introduction
You may like
-
CAS:8027-33-6
$2.00 / 25KG
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$30.00/2mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-07-15 | |
$0.00/25KG |
VIP6Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2022-06-29 | |
$0.00/10G |
VIP2Y
|
Watson Biotechnology Co.,Ltd
|
2024-08-06 | |
$47.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-07-18 |